Career history of Jaak Minten
Former positions of Jaak Minten
Companies | Position | Start | End |
---|---|---|---|
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Corporate Officer/Principal | - | 2013-08-06 |
Katholieke Universiteit Leuven | Corporate Officer/Principal | 1984-12-31 | 1984-12-31 |
CELYAD ONCOLOGY SA | Corporate Officer/Principal | 2012-12-31 | - |
Medtronic GmbH
Medtronic GmbH Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic GmbH is a German company that offers women's health treatments and therapies. The company is based in Meerbusch, Germany and was founded in 1970. The company has recently received FDA approval for their Minimed™ 780g system, which provides real-time insulin adjustments and corrections. The CEOs are Sylvia Theis and Michael Clark Genau. Medtronic is committed to transforming healthcare by working with new partners in new ways, and their innovations have already changed the lives of more than 65 million people worldwide last year. | Corporate Officer/Principal | - | - |
Training of Jaak Minten
Katholieke Universiteit Leuven | Doctorate Degree |
Statistics
International
Belgium | 4 |
Germany | 2 |
Operational
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CELYAD ONCOLOGY SA | Health Technology |
Private companies | 2 |
---|---|
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Health Technology |
Medtronic GmbH
Medtronic GmbH Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic GmbH is a German company that offers women's health treatments and therapies. The company is based in Meerbusch, Germany and was founded in 1970. The company has recently received FDA approval for their Minimed™ 780g system, which provides real-time insulin adjustments and corrections. The CEOs are Sylvia Theis and Michael Clark Genau. Medtronic is committed to transforming healthcare by working with new partners in new ways, and their innovations have already changed the lives of more than 65 million people worldwide last year. | Health Technology |
- Stock Market
- Insiders
- Jaak Minten
- Experience